Literature DB >> 2522549

Colorectal liver metastases: is 'no treatment' still best?

T G Allen-Mersh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2522549      PMCID： PMC1291951          DOI： 10.1177/014107688908200102

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  19 in total

1.  A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.

Authors:  W D Ensminger; A Rosowsky; V Raso; D C Levin; M Glode; S Come; G Steele; E Frei
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

2.  Editorial: Large-bowel cancer-The current status of treatment.

Authors:  S K Carter
Journal:  J Natl Cancer Inst       Date:  1976-01       Impact factor: 13.506

3.  The metastatic spread of cancers of the digestive system in man.

Authors:  E Viadana; I D Bross; J W Pickren
Journal:  Oncology       Date:  1978       Impact factor: 2.935

4.  Further clinical studies with intrahepatic arterial infusion with 5-fluorouracil.

Authors:  F J Ansfield; G Ramirez; H L Davis; G W Wirtanen; R O Johnson; G T Bryan; F B Manalo; E C Borden; T E Davis; M Esmili
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

5.  The clinical correlation of an autopsy study of recurrent colorectal cancer.

Authors:  J P Welch; G A Donaldson
Journal:  Ann Surg       Date:  1979-04       Impact factor: 12.969

6.  Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer.

Authors:  T G Allen-Mersh; N Kemeny; D Niedzwiecki; B Shurgot; J M Daly
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

7.  Predicting tumor response in patients with colorectal hepatic metastases.

Authors:  J M Daly; J Butler; N Kemeny; S D Yeh; J A Ridge; J Botet; J R Bading; J J DeCosse; R S Benua
Journal:  Ann Surg       Date:  1985-09       Impact factor: 12.969

8.  Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.

Authors:  D C Hohn; A A Rayner; J S Economou; R J Ignoffo; B J Lewis; R J Stagg
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

9.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

Authors:  N Kemeny; J Daly; B Reichman; N Geller; J Botet; P Oderman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

10.  Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).

Authors:  N Kemeny; A Yagoda; D Braun
Journal:  Cancer       Date:  1983-01-01       Impact factor: 6.860
View more
  4 in total

1.  Improving survival after large bowel cancer.

Authors:  T G Allen-Mersh
Journal:  BMJ       Date:  1991-09-14

2.  Regulation of spreading and growth of colon cancer cells by hepatocyte growth factor.

Authors:  W G Jiang; D Lloyds; M C Puntis; T Nakamura; M B Hallett
Journal:  Clin Exp Metastasis       Date:  1993-05       Impact factor: 5.150

3.  Evaluation of a follow-up programme after curative resection for colorectal cancer.

Authors:  J D Howell; H Wotherspoon; E Leen; T C Cooke; C S McArdle
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

4.  The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour.

Authors:  J A Goldberg; T Murray; D J Kerr; N Willmott; R G Bessent; J H McKillop; C S McArdle
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.